Our Latest News - BUHLMANN

BUHLMANN News

Classical and Lectin Complement Pathway Activity in Polyneuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citations: Stork AC et al.; Classical and lectin complement pathway activity in polyneuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol. 2016 Jan 15; 290:76-9. PMID:26711574 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Anti-ganglioside Antibodies were not Detected in Human Subjects Infected with or Vaccinated Against 2009 Pandemic Influenza A (H1N1) Virus

Anti-GM1 Autoantibodies ELISA Citation: Lei T et al. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus. Vaccine. 2012 Mar 30; 30(16):2605-10.PMID:22342549 Highlight from this Publication "Anti-ganglioside antibodies, which might be associated with the development of GBS, were previously reported to be induced in mice
Continue Reading

The Presence of Mycoplasma Pneumoniae Infection and GM1 Ganglioside Antibodies in Guillain-Barré Syndrome

BÜHLMANN GanglioCombi ELISA Citation: Sharma MB et al.: The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome. J Infect Dev Ctries. 2011 Jul 4; 5(6):459-64. PMID:21727645.   Highlight from this Publication "Significant difference in levels of anti GM1 ganglioside antibodies (IgG & IgM) was seen between GBS patients and non-neurological controls, highlighting
Continue Reading

Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited

BÜHLMANN GanglioCombi® MAG ELISA Citation Kollewe K et al.; Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited. PLoS One. 2015 Apr 14; 10(4):e0125339.     Highlight from this Publication "In the present study, we describe for the first time the utilization of a state of the art-ELISA assay to obtain reliable data on the occurrence of IgG
Continue Reading

Fecal Calprotectin in Healthy Children Aged 1-4 Years

BÜHLMANN fCAL® ELISA Citation: Zhu, Q,Feng Li, Junli Wang, Lixiao Shen, Xiaoyang Sheng. Fecal Calprotectin in Healthy Children Aged 1-4 Years, PLOS ONE. 2016. http://dx.doi.org/10.1371/journal.pone.0150725.

Highlight from this Publication:

“Children aged from 1 to 4 years old have lower FC concentrations compared with healthy infants (<1years), and higher FC concentrations when comparing with children older than 4 years and adults.”
Continue Reading

Special Pricing on Select Allergens, Assays, and Assay Components

Limited time offer Contact BUHMANN Today for More Details!
Continue Reading

Connect with us at AMLI 2016!

When: August 14-17, 2016 Where:PITTSBURGH, PA Booth: #14 Learn More: AMLI 2016
Continue Reading

BÜHLMANN CAST® Drug Allergens: New Products

We are pleased to announce 2 new BÜHLMANN CAST® Drug Allergens: Tramadol and Metoprolol In order to meet the needs of your Cellular Allergy testing, we are offering an extended allergen portfolio by enriching this product line with new Analgesic and Beta Blocker allergens. Tramadol and Metroprolol are for Research Use Only.  Not for use in diagnostic procedures.
Continue Reading

Comparison of Three Tests for Faecal Calprotectin in Children and Young Adults: a Retrospective Monocentric Study

BÜHLMANN fCAL® ELISA Citation: Prell, C, Nagel D, Freudenberg H, Schwarzer A, Koletzko S. Comparison of three tests for faecal calprotectin in children and young adults: a retrospective monocentric study, BMJ Open. 2014;4:e004558 doi:10.1136/bmjopen-2013-004558.

Highlights from this Publication

“In conclusion, measurement of FC in paediatric patients with unspecific symptoms is very helpful in order to avoid invasive procedure.”
Continue Reading

Are We Exposing Patients with a Mildly Elevated Faecal Calprotectin to Unnecessary Investigations?

BÜHLMANN fCAL®ELISA Citation: Seenan, JP, Thomson, Rankin K, Smith K, Gaya DR. Are we exposing patients with a mildly elevated faecal calprotectin to unnecessary investigations? Gastroenterology. 2014 Frontline Gastroenterol doi:10.1136/flgastro-2014-100467.

Highlight from this Publication:

“...we propose an alternative diagnostic approach of repeating the FC after 6-8 weeks in patients with values of 100-200 µg/g.”
Continue Reading